ProteinChip Technology Reveals Distinctive Protein Expression Profiles in the Urine of Bladder Cancer Patients

This publication has 30 references indexed in Scilit:

• TELOMERASE ACTIVITY AND CYTOKERATIN 20 AS MARKERS FOR THE DETECTION AND FOLLOWUP OF TRANSITIONAL CELL CARCINOMA: AN UNFULFILLED PROMISE
  Journal of Urology, 2001
• Proteomic Approaches within the NCI Early Detection Research Network for the Discovery and Identification of Cancer Biomarkers
  Annals of the New York Academy of Sciences, 2001
• Bladder Cancer
  European Urology, 2001
• Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
  Prostate Cancer and Prostatic Diseases, 1999
• Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer
  British Journal of Cancer, 1999
• Telomerase activity in patients with transitional cell carcinoma
  Cancer, 1999
• PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
  Published by Wolters Kluwer Health ,1998
• Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis
  Science, 1996
• Detection of bladder tumors by immunostaininc of the lewis x antigen in cells from voided urine
  Urology, 1995
• Soluble forms of the adhesion molecule E-cadherin in urine.
  Journal of Clinical Pathology, 1995